Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/41527
metadata.artigo.dc.title: The use of ibuprofen to treat fever in COVID-19: a possible indirect association with worse outcome?
metadata.artigo.dc.creator: Jamerson, Brenda D.
Haryadi, T. Ho
metadata.artigo.dc.subject: COVID-19
Ibuprofen
Fever
metadata.artigo.dc.publisher: Elsevier
metadata.artigo.dc.date.issued: Nov-2020
metadata.artigo.dc.identifier.citation: JAMERSON, B. D.; HARYADI, T. H. The use of ibuprofen to treat fever in COVID-19: a possible indirect association with worse outcome? Medical Hypotheses, [S.l.], v. 144, Nov. 2020.
metadata.artigo.dc.description.abstract: Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.
metadata.artigo.dc.identifier.uri: https://www.sciencedirect.com/science/article/pii/S0306987720309488
http://repositorio.ufla.br/jspui/handle/1/41527
metadata.artigo.dc.language: en_US
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.